A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Research explained

BPC-157 and bleeding after amputation in rats

The study does not establish human surgical bleeding prevention or a safe drug combination.

On this page

Read the experiment

The finding and its boundary

The report describes reduced bleeding-related findings under several experimental conditions. The study does not establish human surgical bleeding prevention or a safe drug combination.

Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.

Experiment
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Study system
Rats undergoing tail or foot amputation with selected antithrombotic challenges
Measured outcome
Bleeding amount/time, platelet counts and selected coagulation measures
Reported result
The report describes reduced bleeding-related findings under several experimental conditions.
What this cannot establish
The study does not establish human surgical bleeding prevention or a safe drug combination.
Open the primary paper

What was actually tested

Rats undergoing tail or foot amputation with selected antithrombotic challenges. The investigators measured bleeding amount/time, platelet counts and selected coagulation measures. The report describes reduced bleeding-related findings under several experimental conditions.

The detail that changes the takeaway

The injury and drug exposure jointly define the result. A shorter bleeding time alone cannot establish the best clinical balance between thrombosis and bleeding. The tested regimen is an experimental intervention, not a reason to change medication before a procedure without the treating team's advice.

How far the result travels

The study does not establish human surgical bleeding prevention or a safe drug combination.

A useful comparison

BPC-157 and drug-induced QTc changes examines eCG QTc measurements after acute and repeated exposure. Here, the measured endpoint was bleeding amount/time, platelet counts and selected coagulation measures. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the Can one BPC-157 study support the product in front of you? appraisal.

References & product documents

The evidence and service information used here.

  1. BPC-157 and bleeding after amputation in rats — original indexed research

Next in the field guide

The provider file
  1. 01

    BPC-157 and drug-induced QTc changes

    The work does not establish prevention of dangerous arrhythmias or safe combinations in patients.

  2. 02

    Can one BPC-157 study support the product in front of you?

    Match the claim, ingredient, route and outcome. A relevant paper can still leave the central purchasing question unanswered.

  3. 03

    BPC-157 after an insulin-overdose rat challenge

    The study is not a human rescue protocol and does not establish safe modification of insulin therapy.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review